Clinical trials
Recruiting Observational Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| Istituti Clinici Scientifici Maugeri SpA | 2 |
| Royal Marsden NHS Foundation Trust | 2 |
| A2 Biotherapeutics Inc. | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Center Eugene Marquis | 1 |
| Centre Francois Baclesse | 1 |
| Cofactor Genomics, Inc. | 1 |
| Elephas | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 32 |
| Breast Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Carcinoma, Renal Cell | 3 |
| Colorectal Neoplasms | 3 |
| Head and Neck Neoplasms | 2 |
| Kidney Neoplasms | 2 |
| Melanoma | 2 |
| Neoplasm, Residual | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.